Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models

被引:94
|
作者
Kulak, Anita [1 ]
Steullet, Pascal [1 ]
Cabungcal, Jan-Harry [1 ]
Werge, Thomas [2 ]
Ingason, Andres [2 ]
Cuenod, Michel [1 ]
Do, Kim Quang [1 ]
机构
[1] Univ Lausanne Hosp, Ctr Psychiat Neurosci, Dept Psychiat, Prilly, Switzerland
[2] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark
基金
瑞士国家科学基金会;
关键词
N-ACETYL-CYSTEINE; LIGASE MODIFIER SUBUNIT; MAGNETIC-RESONANCE-SPECTROSCOPY; GLUTATHIONE-DEFICIENT MICE; DOPAMINE UPTAKE INHIBITION; ANTERIOR CINGULATE CORTEX; PITUITARY-ADRENAL AXIS; TERM SPATIAL MEMORY; PREFRONTAL CORTEX; PREPULSE INHIBITION;
D O I
10.1089/ars.2012.4858
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Schizophrenia (SZ) and bipolar disorder (BD) are classified as two distinct diseases. However, accumulating evidence shows that both disorders share genetic, pathological, and epidemiological characteristics. Based on genetic and functional findings, redox dysregulation due to an imbalance between pro-oxidants and antioxidant defense mechanisms has been proposed as a risk factor contributing to their pathophysiology. Recent Advances: Altered antioxidant systems and signs of increased oxidative stress are observed in peripheral tissues and brains of SZ and BD patients, including abnormal prefrontal levels of glutathione (GSH), the major cellular redox regulator and antioxidant. Here we review experimental data from rodent models demonstrating that permanent as well as transient GSH deficit results in behavioral, morphological, electrophysiological, and neurochemical alterations analogous to pathologies observed in patients. Mice with GSH deficit display increased stress reactivity, altered social behavior, impaired prepulse inhibition, and exaggerated locomotor responses to psychostimulant injection. These behavioral changes are accompanied by N-methyl-D-aspartate receptor hypofunction, elevated glutamate levels, impairment of parvalbumin GABA interneurons, abnormal neuronal synchronization, altered dopamine neurotransmission, and deficient myelination. Critical Issues: Treatment with the GSH precursor and antioxidant N-acetylcysteine normalizes some of those deficits in mice, but also improves SZ and BD symptoms when given as adjunct to antipsychotic medication. Future Directions: These data demonstrate the usefulness of GSH-deficient rodent models to identify the mechanisms by which a redox imbalance could contribute to the development of SZ and BD pathophysiologies, and to develop novel therapeutic approaches based on antioxidant and redox regulator compounds. Antioxid. Redox Signal. 18, 1428-1443.
引用
收藏
页码:1428 / 1443
页数:16
相关论文
共 50 条
  • [31] Obsessive-compulsive disorder: Insights from animal models
    Szechtman, Henry
    Ahmari, Susanne E.
    Beninger, Richard J.
    Eilam, David
    Harvey, Brian H.
    Edemann-Callesen, Henriette
    Winter, Christine
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 76 : 254 - 279
  • [32] Neuroactive steroids are altered in schizophrenia and bipolar disorder: Relevance to pathophysiology and therapeutics
    Marx, Christine E.
    Stevens, Robert D.
    Shampine, Lawrence J.
    Uzunova, Veska
    Trost, William T.
    Butterfield, Marian I.
    Massing, Mark W.
    Hamer, Robert M.
    Morrow, A. Leslie
    Lieberman, Jeffrey A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 (06) : 1249 - 1263
  • [33] GLIA-EXTRACELLULAR MATRIX INTERACTIONS IN THE PATHOPHYSIOLOGY OF SCHIZOPHRENIA AND BIPOLAR DISORDER
    Berretta, Sabina
    Chelini, Gabriele
    Pantazopoulos, Harry
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S16 - S16
  • [34] Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia
    Altamura, A. Carlo
    Buoli, Massimiliano
    Pozzoli, Sara
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 68 (01) : 21 - 36
  • [35] Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and Therapeutics
    Christine E Marx
    Robert D Stevens
    Lawrence J Shampine
    Veska Uzunova
    William T Trost
    Marian I Butterfield
    Mark W Massing
    Robert M Hamer
    A Leslie Morrow
    Jeffrey A Lieberman
    Neuropsychopharmacology, 2006, 31 : 1249 - 1263
  • [36] The role of tumour necrosis factor in the pathophysiology of major depressive disorder, bipolar disorder and schizophrenia
    Gibbons, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 40 - 40
  • [37] Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models
    O'Donnell, Patricio
    SCHIZOPHRENIA BULLETIN, 2011, 37 (03) : 484 - 492
  • [38] DEVELOPMENTAL CRITICAL PERIOD IN GENETIC REDOX DYSREGULATION: ANIMAL AND HUMAN STUDIES IN SCHIZOPHRENIA
    Do, Kim Q.
    Conus, P.
    Bovet, P.
    Cabungcal, J. H.
    Frank, A.
    Gysin, R.
    Lavoie, S.
    Polari, A.
    Steullet, P.
    Teichmann, T.
    Cuenod, M.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 106 - 107
  • [39] Disease reporter cell models for studying the pathophysiology of bipolar disorder
    Tseng, M.
    McCurdy, R. D.
    Witterick, I. J.
    Li, P.
    Warsh, J. J.
    BIPOLAR DISORDERS, 2009, 11 : 86 - 87
  • [40] Dysregulation of the Actin Cytoskeleton Contributes to Dendritic Arbor Pathology in Schizophrenia and Bipolar Disorder
    Konopaske, Glenn
    Balu, Darrick
    Presti, Kendall
    Benes, Francine
    Coyle, Joseph
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S229 - S229